FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’
The agency is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
Regulation
Surge in RMAT designations awarded by the FDA
Makary resigns, with Diamantas named as acting FDA commissioner
Widespread US shift from prescription to OTC lies in pharma’s hands
Rare disease developers applaud clarity in FDA guidance
FDA’s commissioner vouchers prompt questions about award process
Medical bodies sound alarm over US hepatitis B vaccine vote
FDA appoints Tracy Beth Høeg as fifth CDER head this year
